Medtronic PLC (MDT) News
Filter MDT News Items
MDT News Results
|Loading, please wait...|
MDT News Highlights
- For MDT, its 30 day story count is now at 22.
- Over the past 12 days, the trend for MDT's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about MDT are META, MA and RYAN.
Latest MDT News From Around the Web
Below are the latest news stories about MEDTRONIC PLC that investors may wish to consider to help them evaluate MDT as an investment opportunity.
The Zacks Analyst Blog Highlights Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial
Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial are included in this Analyst Blog.
Key Insights The projected fair value for Medtronic is US$87.65 based on 2 Stage Free Cash Flow to Equity With US$79.99...
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), JPMorgan Chase & Co. (JPM) and Salesforce, Inc. (CRM).
Human Rights Campaign Foundation recognizes the company's ongoing commitment to inclusion, diversity, and equityNORTHAMPTON, MA / ACCESSWIRE / December 1, 2023 / Recognizing the company's ongoing commitment to inclusion, diversity, and equity (ID&E) ...
Unveiling the Strengths and Challenges: A Detailed SWOT Analysis of Medtronic PLC (MDT)
A well-rounded portfolio of tech stocks blends growth and value while capturing long-term upside and solid financials
In this article, we will look into the 20 most fit countries in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Fit Countries in the World. According to the WHO, the worldwide prevalence of obesity and overweight tripled between 1975 and 2016. While some countries […]
Medtronic (NYSE: MDT) is a medical device giant that has generated billions of dollars in earnings over time thanks to its diabetes, cardiovascular, neuroscience, and medical-surgical platforms. Considering all this, is Medtronic a buy today, or would it be better to avoid the stock and seek out other opportunities? Motley Fool contributors Adria Cimino and Keith Speights offer their bull and bear cases.
GE HealthCare, Johnson & Johnson and Danaher completed transactions this year. Baxter, 3M and Medtronic are now on deck.
These robotics stocks all deserve a place in your portfolio.